Apperloo EM, Neuen BL, Fletcher RA et al (2024) Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
References PubMed: Physiology of GLP-1 DrugBank: GLP-1 biological role NCBI Bookshelf: Incretin hormones overview StatPearls: GLP-1 physiology [Textbook: Goodman & Gilmans The Pharmacological Basis of Therapeutics, 13th ed.]
Additionally, certain pharmacological agents, including cisplatin, downregulate renal OCTN2 expression, increasing urinary carnitine excretion and potential deficiency states (19)
Glucagon-like peptide 1 therapy: from discovery to type 2 diabetes and beyond
Trans-anethole, a terpenoid ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats
While oral L-Carnitine supplements are available, their absorption can be limited